MA28844B1 - Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol - Google Patents

Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol

Info

Publication number
MA28844B1
MA28844B1 MA29728A MA29728A MA28844B1 MA 28844 B1 MA28844 B1 MA 28844B1 MA 29728 A MA29728 A MA 29728A MA 29728 A MA29728 A MA 29728A MA 28844 B1 MA28844 B1 MA 28844B1
Authority
MA
Morocco
Prior art keywords
ethynyltradiol
drospirenone
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
MA29728A
Other languages
English (en)
Inventor
Carlos Ariel Sandrone
Jose Mario Sakson
Basaistegui Maria Del Carmen Cajarville
Pomi Jose Daniel Larrosa
Original Assignee
Liconsa Laboratorios Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28844(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Laboratorios Sa filed Critical Liconsa Laboratorios Sa
Publication of MA28844B1 publication Critical patent/MA28844B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA29728A 2004-08-09 2007-03-02 Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol MA28844B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04103837A EP1625849A1 (fr) 2004-08-09 2004-08-09 Composition pharmaceutique contenant ethinylestradiol et drospirenone

Publications (1)

Publication Number Publication Date
MA28844B1 true MA28844B1 (fr) 2007-09-03

Family

ID=34929434

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29728A MA28844B1 (fr) 2004-08-09 2007-03-02 Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol

Country Status (19)

Country Link
US (1) US20090227546A1 (fr)
EP (2) EP1625849A1 (fr)
JP (1) JP2008509195A (fr)
KR (1) KR20070045247A (fr)
CN (1) CN101022811B (fr)
AR (1) AR045576A1 (fr)
AT (1) ATE464053T1 (fr)
AU (1) AU2005271206B2 (fr)
BR (1) BRPI0513938B8 (fr)
CA (1) CA2574997A1 (fr)
DE (1) DE602005020694D1 (fr)
ES (1) ES2344356T3 (fr)
IL (1) IL180899A0 (fr)
MA (1) MA28844B1 (fr)
NO (1) NO20071297L (fr)
RU (1) RU2007108666A (fr)
UA (1) UA87513C2 (fr)
WO (1) WO2006015956A1 (fr)
ZA (1) ZA200702038B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (fr) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Formes posologiques solides se désintégrant oralement comprenant de la progestine et leurs procédés de fabrication et d'utilisation
HUP0700826A3 (en) * 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
PT2413912T (pt) 2009-04-01 2019-06-11 Bial Portela & Ca Sa Formulações farmacêuticas compreendendo derivados de nitrocatecol e métodos para as produzir
BRPI1016132B8 (pt) * 2009-04-01 2021-05-25 Bial Portela & Ca Sa composição, formulação farmacêutica, processo de obtenção de uma formulação farmacêutica estável
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) * 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
CN102274235B (zh) * 2011-06-27 2013-03-13 潍坊中狮制药有限公司 一种新的避孕药物组合及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6027747A (en) * 1997-11-11 2000-02-22 Terracol; Didier Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
JP4354667B2 (ja) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
CN1223350C (zh) * 1999-08-31 2005-10-19 先灵公司 用作避孕剂的炔雌醇和屈螺酮的药物联合形式
PT1591121E (pt) * 2000-12-14 2009-07-20 Ortho Mcneil Janssen Pharm Processo para preparar produtos de hormona esteróide compreendendo um agente estabilizante na forma não cristalina
EP1216712A1 (fr) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Complexes d'inclusion de drospirenone et de cyclodextrines

Also Published As

Publication number Publication date
HK1109579A1 (en) 2008-06-13
CN101022811A (zh) 2007-08-22
ZA200702038B (en) 2008-08-27
NO20071297L (no) 2007-05-02
IL180899A0 (en) 2007-07-04
US20090227546A1 (en) 2009-09-10
UA87513C2 (ru) 2009-07-27
CA2574997A1 (fr) 2006-02-16
ES2344356T3 (es) 2010-08-25
DE602005020694D1 (de) 2010-05-27
ATE464053T1 (de) 2010-04-15
JP2008509195A (ja) 2008-03-27
EP1625849A1 (fr) 2006-02-15
AU2005271206A1 (en) 2006-02-16
CN101022811B (zh) 2010-09-15
KR20070045247A (ko) 2007-05-02
RU2007108666A (ru) 2008-09-20
WO2006015956A1 (fr) 2006-02-16
EP1848441A1 (fr) 2007-10-31
AR045576A1 (es) 2005-11-02
BRPI0513938A (pt) 2008-05-20
BRPI0513938B8 (pt) 2021-05-25
BRPI0513938B1 (pt) 2018-09-25
AU2005271206B2 (en) 2009-11-26
EP1848441B1 (fr) 2010-04-14

Similar Documents

Publication Publication Date Title
MA28844B1 (fr) Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol
FR24C1004I1 (fr) Formes galéniques de ganaxolone et procédés de preparation et d'utilisation de celles-ci
EP1765379A4 (fr) Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees
MA29090B1 (fr) Composes inhibiteurs de la phosphorylase du glycogene et compositions pharmaceutiques les comprenant
EE05475B1 (et) Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
EP1513825A4 (fr) Medicament anti-tuberculeux: compositions et methodes
FR2867962B1 (fr) Plaque d'osteosynthese et spherique
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
IL172507A0 (en) New biological entities and the pharmaceutical or diagnostic use thereof
EP1589996A4 (fr) Preparation d'anticorps anti-integrine alpha beta 3 et utilisations associees
EP2128253A4 (fr) Anticorps anti-fgf23 et composition pharmaceutique le comprenant
FR2871695B1 (fr) Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
FR2866617B1 (fr) Plancher elastique et couloir d'intercirculation le comprenant
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
EP1819323A4 (fr) Composition pharmaceutique renfermant un agent d'anti-nucleation
EP1482937A4 (fr) Nouveaux tyloindicines et composes s'y rapportant, compositions pharmaceutiques et methodes
EP1711490A4 (fr) Inhibiteur de p-glycoproteine, procede de preparation, et composition pharmaceutique le renfermant
EP1837382A4 (fr) Composition d'agent de revetement et utilisation de la composition
EP2034829A4 (fr) Composition pharmaceutique comprenant la cyclobenzaprine et l'acéclofénac en association
IL184487A0 (en) N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application